Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Genopole’s citizens

Genopole: Networked development


Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Technician on Genopole bioproduction platform Technician on Genopole bioproduction platform
Key figures
  • 2351

    direct jobs

  • 83

    biotech companies

  • 17

    academic research laboratories

  • 8

    partners specialized in innovation

The founders of Genopole 20 years later

Our founders


Genopole benefits from the unwavering support of the French State for its mission to durably develop a model unique in France.

Read more
Directories of our members

Public research laboratories


17 laboratories carrying out research on a foundation of encouraging and supporting scientific innovation

Portfolio companies


83 businesses spanning such fields as health, bioinformatics, chemistry, food & agriculture and medical devices.

Shared-use platforms


25 technological platforms and ancillary services for Genopole’s scientific community.

Board of directors

Our Team


The Genopole team accompanies researchers & business creators, brings life to the biocluster and seeks to favor well-being at work.

Discover
Testimonials
Antoine Hubert CEO Ÿnsect

“Our accommodation at Genopole allowed us to create not only a laboratory for raising and transforming insects but also a production unit for research purposes.”

A. Hubert
Ÿnsect

Cyrille Pauthenier - CEO Abolis

«Setting up business at Genopole gave us access to equipment that we would not have been able to acquire alone. The special “Technological Potential” prize of the Genopole competition opened doors to other competitions.»

C. Pauthenier
Abolis Biotechnologies

Enterome Laurent Chene

«At Genopole, we found a place where we are able to commit ourselves to research, where the necessary materials and human competencies are present. The Genopole environment increases the confidence of industrials…»

L. Chene
Enterome

Genopole’s citizens

News From Genopole’s Actors


News, perspectives, scientific breakthroughs and more, here’s what’s happening at Genopole

AB Science L. Gros

Multiple sclerosis and COVID-19: promising results from AB Science

AB Science has been announcing a series of positive results concerning the efficacy of its product, masitinib, in such pathologies as multiple sclerosis, severe asthma resistant to oral steroids, COVID-19 and amyotrophic lateral sclerosis.

Discover
Placton - Tara Oceans

Bioinformatics and Tara Oceans

A team from the Genomics Metabolics Laboratory (Genoscope – CEA/CNRS/University of Évry) has developed a bioinformatics method for environmental genomics analyses able to identify species and associations of species.

Discover
Globules rouges - Avancées scientifiques

CRISPR-Cas9 for blood and metabolic diseases – Integrare

In an article published in Nature Communications, an Integrare team headed by Dr. Mario Amendola has described an innovative genome editing strategy aimed at modifying hematopoietic stem cells.

Discover
Généthon - Genopole's Laboratory

Treating more patients with gene therapies – Généthon

A Genethon team has successfully inhibited immune response to adeno-associated virus vectors, and in so doing, opened potential paths for treating more patients with gene therapies.

Discover
COVID-19 Disease Map

A single interactive map for all that is known on COVID-19

The objective for this latter is to build a sole referential comprising the totality of scientific knowledge on SARS-CoV-2/human-host interactions and thus contribute to the identification of therapeutic possibilities.

Discover
cellular membrane

Mapping membrane nanotubes – Lambe

A team from the Genopole-accredited Laboratory for Analysis and Modeling in Biology and the Environment (Lambe) has developed an experimental technique to study cell membrane nanotubes. These largely unknown structures play an essential role in cellular biomolecule transport.

Discover
Laboratory

Toward the industrialization of gene therapies -Polytheragene

Polytheragene is developing a polymer that will improve upon the current market standards for the production of viral particles for therapeutics. The polymer will be used by Genethon and Yposkesi to enhance the bioproduction of gene therapy vectors.

Discover
Jean Weissenbach

Jean Weissenbach: a portrait

Jean Weissenbach, a pioneer in France for the exploration of the human genome and a scientific icon at Genopole, talks about his career in an interview published 18 March 2020 in CNRS News.

Discover
cellular membrane

A nanopore to identify amino acids – Lambe

A team from the Laboratory for Analysis and Modeling in Biology and the Environment (Lambe – University of Évry/University of Cergy-Pontoise/CNRS) used a natural aerolysin nanopore to successfully identify 13 of the 20 amino acids that make up proteins.

Discover
Genopole - European projects

Green light from Europe for the Genopole-coordinated project GEN.ERA

Le projet européen GEN.ERA*, coordonné par Genopole, est sélectionné par la Commission européenne. Il vise à renforcer par une coopération entre clusters, l’internationalisation d’entreprises du secteur de la génomique au-delà du continent européen.

Discover
actus

New accomplishment in gene therapies

A clinical trial for a gene therapy to treat a severe immunodeficiency has provided highly promising initial results.

Discover
View all >
With support